DHR – danaher corporation (US:NASDAQ)

News

Barclays and Evercore Stay Positive on Danaher (DHR) Despite Cutting Price Targets [Yahoo! Finance]
How Danaher's Expanded Infectious Disease Partnership Could Shape DHR's Recurring Revenue Story [Yahoo! Finance]
Danaher (DHR) was given a new $249.00 price target by Robert W. Baird.
Danaher (DHR) was given a new $205.00 price target by Rothschild & Co Redburn.
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com